Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency
Authors:
- Tami JohnTJTami John
- Jolan E. WalterJWJolan E. Walter
- Catherina SchuetzCSCatherina Schuetz
- Karin ChenKCKarin Chen
- Roshini S. AbrahamRARoshini S. Abraham
- Carmem BonfimCBCarmem Bonfim
- Thomas G. BoyceTBThomas G. Boyce
- Avni Y. JoshiAJAvni Y. Joshi
- Elizabeth KangEKElizabeth Kang
- Beatriz Tavares Costa CarvalhoBCBeatriz Tavares Costa Carvalho
- Arash MahajerinAMArash Mahajerin
- Diane NugentDNDiane Nugent
- 18 August 2016
- journal article
- case report
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 36 (7) , 725-732
Abstract
The use of HLA-identical hematopoietic stem cell transplantation (HSCT) demonstrates overall survival rates greater than 75 % for T-B-NK+ severe combined immunodeficiency secondary to pathogenic mutation of recombinase activating genes 1 and 2 (RAG1/2). Limited data exist regarding the use of HSCT in patients with hypomorphic RAG variants marked by greater preservation of RAG activity and associated phenotypes such as granulomatous disease in combination with autoimmunity. We describe a 17-year-old with combined immunodeficiency and immune dysregulation characterized by granulomatous lung disease and autoimmunity secondary to compound heterozygous RAG mutations. A myeloablative reduced toxicity HSCT was completed using an unrelated bone marrow donor. With the increasing cases of immune dysregulation being discovered with hypomorphic RAG variants, the use of HSCT may advance to the forefront of treatment. This case serves to discuss indications of HSCT, approaches to preparative therapy, and the potential complications in this growing cohort of patients with immune dysregulation and RAG deficiency.Keywords
Funding Information
- Division of Intramural Research
This publication has 26 references indexed in Scilit:
- Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experienceBlood, 2016
- Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantationJournal of Cancer Research and Clinical Oncology, 2015
- Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide AntigensPLOS ONE, 2015
- Identification of Patients with RAG Mutations Previously Diagnosed with Common Variable Immunodeficiency DisordersJournal of Clinical Immunology, 2014
- The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer CellsCell, 2014
- Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesJAMA, 2014
- SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCIDBlood, 2014
- Exome Sequencing Reveals RAG1 Mutations in a Child with Autoimmunity and Sterile Chronic Multifocal Osteomyelitis Evolving into Disseminated Granulomatous DiseaseJournal of Clinical Immunology, 2013
- Expanding the spectrum of recombination-activating gene 1 deficiency: A family with early-onset autoimmunityJournal of Allergy and Clinical Immunology, 2013
- Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantationBone Marrow Transplantation, 2002